[Retracted] Epigenetic silencing of miR‑130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signaling.
Int J Oncol. 2020 Dec;57(6):1383. doi: 10.3892/ijo.2020.5136. Epub 2020 Oct 20.
Int J Oncol. 2020.
PMID: 33174015